Alto Neuroscience (ANRO) Stock Forecast & Price Target

$3.89 +0.17 (+4.57%)

(As of 12/20/2024 04:32 PM ET)

Alto Neuroscience - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
0

Hold
3

Buy
5

Based on 8 Wall Street analysts who have issued ratings for Alto Neuroscience in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 3 have given a hold rating, and 5 have given a buy rating for ANRO.

Consensus Price Target

$20.00
414.14% Upside

According to the 8 analysts' twelve-month price targets for Alto Neuroscience, the average price target is $20.00. The highest price target for ANRO is $43.00, while the lowest price target for ANRO is $4.00. The average price target represents a forecasted upside of 414.14% from the current price of $3.89.

Get the Latest News and Ratings for ANRO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors.

ANRO Analyst Ratings Over Time

Type	Current Forecast 12/23/23 to 12/22/24	1 Month Ago 11/23/23 to 11/22/24	3 Months Ago 9/24/23 to 9/23/24	1 Year Ago 12/23/22 to 12/23/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	5 Buy rating(s)	5 Buy rating(s)	7 Buy rating(s)	N/A
Hold	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$20.00	$20.00	$33.80	N/A
Forecasted Upside	414.14% Upside	364.04% Upside	154.33% Upside	N/A
Consensus Rating	Moderate Buy	Moderate Buy	Buy	N/A

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

ANRO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ANRO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Alto Neuroscience Stock vs. The Competition

Type	Alto Neuroscience	Medical Companies	S&P 500
Consensus Rating Score	2.63	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	414.14% Upside	25,828.59% Upside	14.53% Upside
News Sentiment Rating	Neutral News See Recent ANRO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/13/2024	Stifel Nicolaus 4 of 5 stars		Lower Target	Buy ➝ Buy	$32.00 ➝ $10.00	+111.86%
10/23/2024	RODMAN&RENSHAW 0 of 5 stars	E. Piros Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
10/23/2024	Wedbush 4 of 5 stars	L. Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$29.00 ➝ $4.00	-72.45%
10/23/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$32.00 ➝ $10.00	-31.13%
10/23/2024	Rodman & Renshaw Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
9/10/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
2/27/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
2/27/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$33.00	+115.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:23 AM ET.

ANRO Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Alto Neuroscience is $20.00, with a high forecast of $43.00 and a low forecast of $4.00.
: 8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Alto Neuroscience in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ANRO shares.
: According to analysts, Alto Neuroscience's stock has a predicted upside of 414.14% based on their 12-month stock forecasts.
: Over the previous 90 days, Alto Neuroscience's stock had 3 downgrades by analysts.
: Alto Neuroscience has been rated by research analysts at Robert W. Baird, Rodman & Renshaw, RODMAN&RENSHAW, Stifel Nicolaus, and Wedbush in the past 90 days.
: Analysts like Alto Neuroscience less than other "medical" companies. The consensus rating score for Alto Neuroscience is 2.63 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ANRO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

This page (NYSE:ANRO) was last updated on 12/22/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alto Neuroscience (ANRO) Stock Forecast & Price Target